Death of a Young Client Highlights Gaps in New York Med Spa Regulation
A 27-year-old woman died after an NAD IV+ treatment at a Riverdale med spa, exposing lax oversight in the rapidly expanding industry.
On July 20, 2026, Elizabeth Baron suffered cardiac arrest while receiving an NAD IV+ injection at the Bereshit Lifestyle Center in Riverdale, New York, and was later pronounced dead. The clinic was run by Luis Rojas Cabrera, who asserted he held a medical license from the Dominican Republic, and he allegedly made statements after the incident. Baron's fatality has shone a spotlight on the fast-growing med spa sector, which has expanded sixfold nationwide since 2010 and is projected to reach $47 billion within five years.
Oversight in New York is fragmented among several agencies, and loopholes allow businesses to list distant or retired physicians as “medical directors” while nurses perform procedures with limited supervision. Recent prosecutions for lethal overdoses and counterfeit Botox illustrate the potential for serious harm. Experts warn that the blend of aggressive marketing, low-cost business models, and ambiguous legal definitions makes it hard for regulators and patients to distinguish legitimate providers from those operating in a gray area.
Why it matters
The case reveals how minimal regulation can endanger consumers in a booming, poorly supervised aesthetic-medicine market.
In this story